Docetaxel as Neoadjuvant Chemotherapy in Patients With Advanced Cervical Carcinoma

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Clinical Oncology

• Publication date

  2003-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.coc.0000037109.12434.52PMID 14528074
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

  2002cited by this paper
• Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group.

  2002cited by this paper
• Neoadjuvant Chemotherapy With Ifosfamide, Cisplatin, and Vinorelbine in Advanced Squamous Cell Carcinoma of the Cervix

  2000cited by this paper
• Concurrent chemotherapy and radiation: a major advance for women with cervical cancer.

  1999cited by this paper
• Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.

  1999cited by this paper
• Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.

  1999cited by this paper
• Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.

  1999cited by this paper
• Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

  1999cited by this paper
• Vinorelbine as neoadjuvant chemotherapy in advanced cervical carcinoma.

  1997cited by this paper
• Docetaxel: an active drug for squamous cell carcinoma of the head and neck.

  1996cited by this paper
• Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer.

  1995cited by this paper
• Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison.

  1995cited by this paper
• Chemotherapy as a palliative treatment in carcinoma of the uterine cervix.

  1995cited by this paper
• [Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].

  1994cited by this paper
• New approaches to high‐risk cervical cancer: Advanced cervical cancer

  1993cited by this paper
• Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.

  1993cited by this paper
• Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion.

  1993cited by this paper
• Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.

  1993cited by this paper
• Estimates of the worldwide incidence of eighteen major cancers in 1985

  1993cited by this paper
• Phase I trial of Taxotere: five-day schedule.

  1992cited by this paper
• Synergistic effects of taxol/taxotere on radiation sensitivity on human tumor cell lines

  1992cited by this paper
• Relationships between the structure of taxol analogues and their antimitotic activity.

  1991cited by this paper
• Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.

  1991cited by this paper
• Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

  1990cited by this paper
• Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analogues

  1989cited by this paper
• Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix.

  1989cited by this paper
• Highly efficient, practical approach to natural taxol

  1988cited by this paper
• Exploratory data analysis and the use of the hazard function for interpreting survival data: an investigator's primer.

  1985cited by this paper
• Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel‐shaped cervical cancer

  1985cited by this paper
• The importance of dose intensity in chemotherapy of metastatic breast cancer.

  1984cited by this paper
• Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.

  1983cited by this paper
• INVASIVE CERVICAL CANCER

  1981cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper
• Chemotherapy for advanced cervical cancer with bleomycin, vincristine, mitomycin C, and cis-diamminedichloroplatinum(II) (BOMP).

  1980cited by this paper
• Cisplatin (cis-diamminedichloroplatinum II).

  1979cited by this paper
• Promotion of microtubule assembly in vitro by taxol

  1979cited by this paper
• Clinical studies with adjunctive surgery and irradiation therapy in the treatment of carcinoma of the cervix

  1976cited by this paper
• Prognostic Significance of Cervical Lesion Size and Pelvic Node Metastases in Cervical Carcinoma

  1975cited by this paper
• Five Classes of Extended Hysterectomy for Women With Cervical Cancer

  1974cited by this paper
• Analysis of central recurrent disease in stages I and II squamous cell carcinomas of the cervix on intact uterus.

  1970cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Lymph node metastasis-related gene signature shows good performance in predicting prognosis and immune infiltration in cervical cancer

  2023cites this paper
• Advances in paclitaxel combinations for treating cervical cancer

  2020cites this paper
• Role of Difucosylated Lewis Y Antigen in Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Treated with Cisplatin Regimen

  2016cites this paper
• Relevant Role of Di-Fucosylated Ley Antigen in the Outcome of Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin Regimen

  2015cites this paper
• Expression of ERCC1 and TUBB3 in Locally Advanced Cervical Squamous Cell Cancer and its Correlation with Different Therapeutic Regimens

  2015cites this paper
• A comparison of concurrent chemoradiotherapy and radiotherapy in Chinese patients with locally advanced cervical carcinoma: a multi-center study

  2014cites this paper
• In Vitro Chemoresponse Analysis of Cervical Cancer Patient Specimens

  2014cites this paper
• Perbandingan Operabilitas setelah Pemberian Kemoterapi Neoadjuvant Cisplatin dan Paclitaxel-Carboplatin pada Kanker Serviks IIB di Divisi Ginekologi Onkologi RSUD Dr. Soetomo

  2014cites this paper
• Pharmacoethnicity of docetaxel-induced severe neutropenia: integrated analysis of published phase II and III trials

  2013cites this paper
• Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells

  2013cites this paper
• Keberhasilan Kemoterapi Neoajuvan Cisplatin-Vincristine-Bleomycin dan Paclitaxel-Carboplatin Ditinjau dari Penilaian Operabilitas Kanker Serviks IIB

  2012cites this paper
• Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 – IIB) cervical cancer: preliminary results of a single-institution experience

  2011cites this paper
• Phase II Study of Combination Chemotherapy With Docetaxel and Carboplatin for Locally Advanced or Recurrent Cervical Cancer

  2010cites this paper
• A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.

  2009cites this paper
• Phase II Clinical Trial of Docetaxel in Refractory Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study

  2007cites this paper
• Chemotherapy in the management of cervical carcinoma.

  2006cites this paper
• Predicting the chemosensitivity of ovarian and uterine cancers with the collagen gel droplet culture drug-sensitivity test

  2005cites this paper
• Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study.

  2005cites this paper
• Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report

  2004cites this paper